Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications

Far Eastern Memorial Hospital200 enrolled

Overview

This is a randomized study to compare asthma patients using Foster or Relvar.

The Global Asthma Association (GAA) and the World Allergy Organization (WAO) recently issued statements stating that the small airway is caused by asthma and chronic obstructive pulmonary disease (COPD). Both pathogenesis and treatment play an important role. The small airway is an airway with diameter less than 2 mm and is one of the main sites where airflow obstruction occurs. Small particles (\<2 μm) and large particles are more likely to deposit in the distal airways, and have shown to have better effects on asthma and pulmonary obstruction. At the same time, real-life research has also shown that extra-fine particles provide better asthma control than large particles, and can better improve quality of life.The aim of the study is to compare the efficacy of asthma inhalers between extra-fine particles and non-extra-fine particles.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

200

Conditions

Asthma

Interventions

FosterDRUG

a randomized study for comparison asthma patients using Foster or Relvar. The primary end point is lung function improvement evaluation

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients diagnosis with asthma with treatment naive * asthma patients with poor controlled status Exclusion Criteria: * COPD * smoking history * pregnancy * cardiaovascular disease * patients with acute respiratory infection

Locations (1)

Far Eastern Memorial Hospital

Taipei, Taiwan

Outcomes

Primary Outcomes

Lung function improvement

FEV1

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.